top of page
Presentation1_edited.jpg

About Us

Agilis Robotics has designed and developed fully flexible robotic instruments for endoluminal surgery with cutting edge mechanical architecture. The robotic system is able to seamlessly integrate into current clinical workflows and drastically reduce the learning curve associated with endoscopic surgery.  Through the flexible operation altogether with the fully flexible robotic arm, the entire tumour tissue can be effectively removed, especially for early stage cancers of the gastrointestinal tract and urinary tract. The company’s ultimate goal is to provide clinicians with the next-generation of minimally invasive instruments for more effective and affordable early stage care for patients.

News

医疗展创新产品抢市场

​港大学自研科技大晒冷

2023-05-21  文匯

不同大学的科研团队及市场上不同的科研机构展出产品,部分亦已经进入动物测试的阶段,预计不久将来就可以正式面世,势必对本港医疗产业带来重大突破性发展。来自香港大学的Agilis Robotics研发出适用于经自然腔道手术的全柔性的机械臂,针对胃肠道和泌尿道早期癌症的治疗将有突破性的帮助。

国内首次!香港大学孵化的巧捷力医疗机器人成功进行首次活体动物内镜手术测试

2023-05-04  HKU

由香港大学孵化的初创企业巧捷力医疗机器人(下称“巧捷力”),3月29日成功于香港大学深圳医院进行了中国内地首次活体动物(猪)试验。

Success Story Feature at HKU TTO News Letter: Endoscopic surgery by robot

2023-04-25  HKU TTO

Success technology transfer towards commercialization of robot system for endoscopic surgery by Agilis Robotics in monthly newsletter of HKU TTO.

Agilis Robotics has kickstarted its first trial in mainland China, taking a great leap forward in robotized endoscopic surgery in the country

2023-03-21  PR Newswire

Agilis Robotics has just kickstarted its series of pre-clinical tests in mainland hospitals and is set to initiate First-in-Human (FIH) testing in 2024.

Agilis Robotics Completes New Round of Live Animal Trials with Miniaturized Robotic Instruments for Endoscopic Surgery

2023-01-17 PR Newswire

Agilis Robotics, a leading developer of flexible robotic instruments that support endoscopic surgery through natural orifices of the body (e.g. along the gastrointestinal tract and in the bladder), has recently completed the second round of live animal testing using its proprietary robot.

巧捷力医疗机器人完成活体动物测试,目标年底前完成Pre-B轮融资,为首次人体试验开路

 2022-11-17 MedRobot

巧捷力已完成六百万美元的A轮融资,正在进行五百万美元的Pre-B轮融资,目标于2022年底前完成。此轮融资所获资金将用于其机器人系统相关的NMPA及FDA 认证申请,加快产品于中国大陆的市场化进度。值得关注的是,巧捷力预期市值将于2025年前符合于香港交易所上市规则与指引18A章生物科技公司主板上市的申请条件。

医健创科新时代 香港庞大优势尽显
港受惠措拖多 有利科研成果商品化

2023-05-04  信报

巧捷力作为港大衍生的公司,正是强化大学基础科研活动的成功案例。香港作为中港两地投资、科研交流的桥梁,这些政策将有助推动科研成果商品化。

Agilis Robotics' innovative research novelties excel at 48th International Exhibition of Inventions of Geneva

2023-04-29  HKU

Our innovation Ultra-thin Flexible Robotic Instruments for Endoluminal Surgery was awarded Silver Medal at the 48th International Exhibition of Inventions of Geneva

Agilis Robotics conducts first live animal trial for GI indication, targeting 510(k) clearance by 2025 to transform endoscopic surgery

2023-04-19  PR Newswire

Agilis Robotics has recently showcased the system's capabilities in a trial performed on a live pig subject at The University of Hong Kong-Shenzhen Hospital in March. Dr Joe FAN King Man led the trial and successfully performed endoscopic submucosal dissection (ESD) in the upper and lower gastrointestinal tract with the robotic system.

完成中国内地首次测试,巧捷力全球最小全柔性臂内镜手术机器人加速产品落地

2023-03-06  动脉网

近日,巧捷力医疗机器人(以下简称“巧捷力”)自主研发的内镜手术机器人样机于香港大学深圳医院完成中国内地首次测试。本次测试由香港大学深圳医院助理院长樊敬文医生,以及巧捷力团队共同完成。

最小内镜手术机器人:巧捷力完成新一轮活体动物测试

2022-12-21 器械之家

近日,巧捷力医疗机器人自主研发的机器人完成了第二轮活体动物测试。本次测试由公司联合创始人陈英权医生完成,在活体实验猪上进行了经尿道膀胱肿瘤整块切除术(ERBT),手术成功切除了整块人工肿瘤组织,各项测试结果达到预期目标,充分验证巧捷力医疗手术机器人系统的精准性、安全性、有效性。

bottom of page